MetaCap

Nyxoah SA Company Profile

NASDAQ: NYXHHealth CareMedical/Dental InstrumentsUSD

1.36+0.01 (+0.74%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Nyxoah SA at a glance

Nyxoah SA (NASDAQ: NYXH) is a Medical/Dental Instruments company in the Health Care sector headquartered in Mont-Saint-Guibert, Belgium. Nyxoah SA is led by Mr. Olivier Taelman and employs about 153 people. The company's shares have traded publicly since 2021.

At a market capitalization of $138.5 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001857190, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Nyxoah SA do?

Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Business description based on the company's public filings.

Company information

Legal name
Nyxoah SA
Ticker
NASDAQ: NYXH
Sector
Health Care
Industry
Medical/Dental Instruments
CEO
Mr. Olivier Taelman
Employees
153
Headquarters
Rue Edouard Belin 12, Mont-Saint-Guibert, Belgium
Phone
32 1 045 90 75
Website
nyxoah.com
IPO year
2021
Market cap
$138.50M
SEC CIK
0001857190

Companies similar to Nyxoah SA

NYXH peer companies
CompanyPrice% ChgMarket capCompare
KRMDKORU Medical Systems Inc.2.96-1.33%$135.96Mvs NYXH
QTEXQTREX Quantum Ltd.1.87+10.65%$125.43Mvs NYXH
LUCDLucid Diagnostics Inc.0.638-1.86%$121.83Mvs NYXH
STIMNeuronetics Inc.2.13-0.47%$162.30Mvs NYXH
APYXApyx Medical Corporation2.59+9.75%$109.10Mvs NYXH
PYPDPolyPid Ltd.5.07+3.47%$102.98Mvs NYXH
LUNGPulmonx Corporation1.84+1.66%$79.02Mvs NYXH
SKYASkyAI Inc.1.82+7.69%$78.71Mvs NYXH

Related